Privia Health Group (NASDAQ:PRVA - Get Free Report) posted its earnings results on Thursday. The company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.05 by ($0.02), Zacks reports. The business had revenue of $460.90 billion during the quarter, compared to the consensus estimate of $422.01 million. Privia Health Group had a return on equity of 2.02% and a net margin of 0.75%. Privia Health Group updated its FY 2025 guidance to EPS.
Privia Health Group Trading Down 0.0 %
NASDAQ PRVA traded down $0.01 on Monday, hitting $24.96. 1,256,794 shares of the company traded hands, compared to its average volume of 696,067. The company has a market capitalization of $3.00 billion, a price-to-earnings ratio of 249.62, a P/E/G ratio of 3.47 and a beta of 0.87. The business's 50 day moving average price is $22.50 and its 200-day moving average price is $20.64. Privia Health Group has a 52-week low of $15.92 and a 52-week high of $26.04.
Analyst Upgrades and Downgrades
A number of analysts have commented on the company. Piper Sandler lifted their target price on Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a report on Friday. JMP Securities reissued a "market outperform" rating and issued a $26.00 target price on shares of Privia Health Group in a report on Friday, February 14th. Stephens reissued an "overweight" rating and issued a $26.00 target price on shares of Privia Health Group in a report on Thursday, January 2nd. JPMorgan Chase & Co. lifted their target price on Privia Health Group from $27.00 to $28.00 and gave the stock an "overweight" rating in a report on Friday, November 29th. Finally, Truist Financial lifted their price objective on Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a report on Friday, November 8th. One analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $26.47.
Check Out Our Latest Report on Privia Health Group
About Privia Health Group
(
Get Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
See Also
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
